Profilakticheskaya Meditsina最新文献_第9页

Hypertension in the population and prevention in outpatient settings: problems and solutions 高血压在人群和预防在门诊设置:问题和解决方案

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed20232603123

N. Kirilenko, N. N. Ilyina

引用次数: 0

Vitamin D provision, the prevalence of its deficiency, insufficiency, and optimal level in different age groups individuals living in the Russian North 维生素D的提供，其缺乏，不足的患病率，并在不同年龄组的个人生活在俄罗斯北部的最佳水平

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed20232604172

I. Averyanova

引用次数: 0

Clinical and laboratory indicators in predicting the risk of chronic heart failure in COVID-19 survivors 预测COVID-19幸存者慢性心力衰竭风险的临床和实验室指标

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed20232604177

A. O. Shabelsky, A. V. Levshin, P. Astanin, A.E. Kolesova, Ya.E. Nureeva, A. Svarovskaya

{"title":"Clinical and laboratory indicators in predicting the risk of chronic heart failure in COVID-19 survivors","authors":"A. O. Shabelsky, A. V. Levshin, P. Astanin, A.E. Kolesova, Ya.E. Nureeva, A. Svarovskaya","doi":"10.17116/profmed20232604177","DOIUrl":"https://doi.org/10.17116/profmed20232604177","url":null,"abstract":"Coronavirus disease has many systemic disease symptoms and has severe consequences for the cardiovascular system. Objective. To assess the role of clinical and laboratory indicators in determining the risk of chronic heart failure (CHF) in COV-ID-19 survivors. Material and methods. In total, 151 patients treated in a monoinfectious hospital from 03.11.20 to 10.02.21 with a confirmed diagnosis of COVID-19 were retrospectively selected. Medical history and laboratory data were collected by reviewing electronic medical records. The data included age, gender, body mass index, smoking status, and comorbidities. The laboratory data included the results of hematology and blood chemistry, coagulation, and the levels of acute-phase proteins. The CHF occurrence was used as the study endpoint. Results and discussion. The study patients were divided into two groups depending on the presence of CHF: group 1 included 46 patients with CHF, and group 2 included 105 patients without CHF. The median age was 66.2 (50-92) years;91 (60.3%) were females. Laboratory tests, such as levels of the hs-C-reactive protein, lactate dehydrogenase, procalcitonin, creatinine, and bilirubin, were statistically significantly different in patients of the study groups, and the median values were higher in patients with CHF. Neutrophil-lymphocyte ratio (NLR) showed statistically significant differences between groups: in patients with CHF, the median was 4.97% compared to 3.62% (p=0.011) in those without CHF. The most significant predictors of an increased risk of CHF were age >=66 years (OR=8.038, p<0.001), procalcitonin level >=0.09 ng/mL (increased the CHF risk by 3.8 times, p<0.001), thrombocy-topenia <=220x109/L (p=0.010), an NLR ratio >=4.11% (p=0.010), and a history of chronic kidney disease (p=0.018). Conclusion. A model has been developed to determine the factors closely associated with the risk of chronic heart failure in CO-VID-19 survivors.Copyright © 2023, Media Sphera Publishing Group. All rights reserved.","PeriodicalId":37659,"journal":{"name":"Profilakticheskaya Meditsina","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67426929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A case of generalized thrombosis in a young patient with COVID-associated pneumonitis and alveolitis 新冠肺炎伴肺泡炎年轻患者全身性血栓形成1例

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed202326061113

L. P. Romanova, O. Vorobeva

引用次数: 0

Socio-demographic features of alcohol consumption in the Krasnodar urban and rural populations based on the ESSE-RF2 study 基于ESSE-RF2研究的克拉斯诺达尔城乡人口酒精消费的社会人口特征

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed20232604126

S. V. Gubarev, S. Maksimov, G. Muromtseva, E.I. Panchenko, A. Redko

引用次数: 0

Preventive technologies as a tool for students’ education (CINDI project) 预防技术作为学生教育的工具(CINDI项目)

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed20232604151

N. Pyrikova, I. Osipova, O. Antropova, V. Dekhar

引用次数: 0

Characteristics of territorial planning models in healthcare 医疗保健领域规划模式的特点

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed20232607145

A. Polikarpov, M. Sankova, N. Golubev, E. Karakulina, I. Deev, O. Kobyakova

引用次数: 0

Monitoring and evaluation of tobacco control policies: international practices. Part 3. Evaluation of the effects of tobacco control measures: predictive models and natural experiment methods 监测和评价烟草控制政策:国际惯例。第3部分。烟草控制措施效果的评价:预测模型和自然实验方法

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed20232608115

M. Gambaryan

引用次数: 0

Perspectives for eye tracking in managing of patients’ flows in healthcare organizations 眼动追踪在医疗机构患者流量管理中的应用前景

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed20232609118

A.A. Kurmangulov, D.V. Kroshka, V.A. Egorov

引用次数: 0

To the issue of the district therapists shortage in the state out-patient clinics 国家门诊诊所地区治疗师短缺的问题

Profilakticheskaya Meditsina Pub Date : 2023-01-01 DOI: 10.17116/profmed20232610115

E.A. Dobretsova, I.L. Arshukova, I.M. Akulin

引用次数: 0